EUVIMEDDescoperă EUVIMED
EUVIMED · CrossrefJournal

European Journal of Cancer

ISSN 0959-8049 · Elsevier BV

Latest articles

  1. Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)

    Rachel Galot, Christophe Le Tourneau, Lisa Licitra, Joël Guigay, Anthony Kong, Ingeborg Tinhofer, Caroline Even, Amaury Daste, Esma Saada-Bouzid, Frédéric Rolland, Stéphanie Henry, Sylvie Rottey, Emmanuel Seront, Annemie Rutten, Athénais van der Elst, Konstantina Tsechilidou, Lieve Dirix, Catherine Fortpied, Ana Joaquim, Anne-Sophie Govaerts, Jean-Pascal Machiels

    Published: 2026-12DOI: 10.1016/j.ejca.2026.117791

  2. Risk stratification and potential overtreatment in adjuvant CDK4/6 inhibitor trials: do all patients with Stage II disease and favorable biology derive benefit?

    Patrick Neven, Francois Duhoux, Philippe Aftimos, Patrick Berteloot, Evandro de Azambuja, Cleo De Backer, Debbie Debaere, Françoise Derouane, Christel Fontaine, Sileny Han, Greet Huygh, Michail Ignatiadis, Eline Naert, Kevin Punie, Annelies Requilé, Christos Sotiriou, Wiebren Tjalma, Koen Traen, Yannick Van Herck, Hans Wildiers

    Published: 2026-12DOI: 10.1016/j.ejca.2026.117808

  3. From staging to changing strategy: [18F]FDG PET/MRI’s impact on treatment planning in early breast cancer

    Rosa Di Micco, Silvia P. Corona, Vincenzo Bagnardi, Sveva Riccardi, Carla Canevari, Francesca Gallivanone, Lidija Antunovic, Paola Scifo, Ilaria Neri, Fabrizia Gelardi, Patrizia Magnani, Claudio Losio, Elena Venturini, Giovanna Della Vecchia, Goffredo Ferrarese, Nicole Rotmensz, Veronica Zuber, Sara Baleri, Giovanni Cisternino, Francesca Calabretto, Mario Rampa, Ludovica Pitoni, Giulia Viale, Luca Licata, Isabella Sassi, Giampaolo Bianchini, Pietro Panizza, Arturo Chiti, Oreste D. Gentilini

    Published: 2026-12DOI: 10.1016/j.ejca.2026.117809

  4. Osteosarcoma as a second or later malignancy: Presentation, treatment, and survival of 198 patients from the Cooperative Osteosarcoma Study Group

    Alexandru A. Sabo, Stefanie Hecker-Nolting, Stefan S. Bielack, Matthias Kevric, Benjamin Sorg, Mihnea P. Dragomir, Thekla von Kalle, Leo Kager, Michaela Nathrath, Claudia Rossig, Florian Babor, Reinhard Windhager, Judith S. Hecker, Christoph K.W. Deinzer, Peter Reichardt, Markus Metzler, Martin Benesch, Gerda Hofmann-Wackersreuther, Martin Ebinger, Claudia Blattmann

    Published: 2026-12DOI: 10.1016/j.ejca.2026.117813

  5. PELICAN-IPC 2015–016/Oncodistinct-003: A randomized non-comparative phase II study of pembrolizumab in combination with neoadjuvant chemotherapy in HER2-negative inflammatory breast cancer

    Alexandre de Nonneville, Florence Lerebours, Christophe Zemmour, Florence Dalenc, Christelle Levy, Thierry Petit, Marianne Leheurteur, Jean-Yves Pierga, Thomas Bachelot, Sylvain Ladoire, Frédéric Viret, Leonor Lopez Almeida, Muge Kaya, Jean-Marie Boher, François Bertucci, Emmanuelle Charafe, Anthony Gonçalves

    Published: 2026-12DOI: 10.1016/j.ejca.2026.117816

  6. Biomarker-defined benefit from FLOT plus nivolumab in metastatic gastroesophageal cancer: Extended follow-up and immune-inflammatory markers of the phase II IKF-AIO-moonlight trial

    Michael Masetti, Alexander Nieto, Sylvie Lorenzen, Thorsten Oliver Goetze, Peter C. Thuss-Patience, Jorge Riera-Knorrenschild, Eray Goekkurt, Tobias Nicolaas Dechow, Thomas Jens Ettrich, Ralf Dieter Hofheinz, Kim Barbara Luley, Daniel Pink, Udo Lindig, Gunnar Folprecht, Gunter Schuch, Michael Bitzer, Volker Heinemann, Stefan Angermeier, Claus Bolling, Maria Loose, Sabine Junge, Claudia Pauligk, Salah-Eddin Al-Batran, Alexander Stein, Joseph Tintelnot

    Published: 2026-11DOI: 10.1016/j.ejca.2026.117037

  7. Corrigendum to “MRI in advanced ovarian cancer: Multicentre MISSION trial” [Eur J Cancer 238 (2026) 116614]

    Eva Berardi, Willemien J. van Driel, Ralph H.M. Hermans, Katja N. Gaarenstroom, Christianne A.R. Lok, Els L.van Persijn-van Meerten, Joost Nederend, Sandrina Lambrechts, Marta Lopez-Yurda, Maurits P. Engbersen, Charlotte J.V. Rijsemus, Doenja M.J. Lambregts, Andrea Laghi, Arend G.J. Aalbers, Regina G.H. Beets-Tan, Niels F.M. Kok, Max J. Lahaye

    Published: 2026-11DOI: 10.1016/j.ejca.2026.117055

Volumes

2026 · 3492025 · 6862024 · 1,3682023 · 5292022 · 1,2002021 · 7082020 · 9522019 · 5572018 · 1,0062017 · 1,0862016 · 1,6782015 · 2,4802014 · 2,2082013 · 6662012 · 2,8222011 · 2,9712010 · 4442009 · 5272008 · 3882007 · 3882006 · 4732005 · 4292004 · 4872003 · 4422002 · 1,6802001 · 2,4922000 · 4231999 · 1,9101998 · 1,1681997 · 2,3651996 · 1,0041995 · 2,1321994 · 7741993 · 2,2111992 · 518

Cunoștințe potrivite muncii dumneavoastră.

De la începutul gratuit și cercetarea bibliografică personală până la Research Suite complet.

Vezi tarifele →

Sunt incluse toate textele integrale ale editorilor?

Nu. Referințele bibliografice, rezumatele și textele integrale sunt conținuturi diferite. Disponibilitatea unui text integral depinde de sursă, de Open Access și de licențele pe care le aveți deja. Un abonament EUVIMED nu înlocuiește drepturile suplimentare ale editorilor.